Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Crude Futures Rise For Fourth Straight Session As Strait Of Hormuz Tensions Fuel Oil Rally

New Delhi: Crude oil futures rose for the fourth straight session, increasing by Rs 57 to Rs 8,145 per barrel on Wednesday, tracking firm global trends as renewed risks around the Strait of Hormuz deepen concerns over the flow of energy supplies from West Asia. On the Multi Commodity Exchange (MCX), crude oil for September delivery traded higher by Rs 57, or nearly 1 per cent, to Rs 8,145 per…

Crude Futures Rise For Fourth Straight Session As Strait Of Hormuz Tensions Fuel Oil Rally

Crude oil futures experienced a fourth consecutive day of gains, climbing by Rs 57 to Rs 8,145 per barrel on Wednesday. The surge in prices was driven by heightened concerns over shipping and energy supplies stemming from tensions around the Strait of Hormuz. In a bid to satisfy growing global demand, Saudi Aramco resorted to ship-to-ship transfers near the UAE coast, despite the increased costs.

Meanwhile, analysts warn that the attack on a merchant vessel in the region could further disrupt the flow of crude oil through this vital shipping lane.

Written by urgent.news from Free Press Journal's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at freepressjournal.in →

More in Finance & Markets

WEX Says Embedded Payments Are Easier to Launch Than to Scale

Watch more: Need to Know With WEX’s Eric Frankovic Embedded payments can look simple at launch. A company identifies a customer pain point, integrates a payment capability and begins moving transactions through an experience it already controls. Then the challenges come when the embedded finance program starts working.

Rakovina Therapeutics Announces Results from 2026 Annual General Meeting

VANCOUVER, British Columbia, Aug. 19, 2026 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing innovative cancer therapies through AI-powered drug discovery, is pleased to announce the results of voting at its 2026 annual general meeting of shareholders held on August 18, 2026, in…

More from Wednesday 19 August →